INCY  valuation analysis

Name: Incyte Corporation
Description: Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 04, 2021
Market cap: $18.28B (227th)
Sales(TTM): $2.70B (402nd)
Earnings(TTM): $478.48M (254th)

FFER: 1.25 (why)
Actual price: $83.12
FFEThis is Incyte Corporation's the estimated price. FFEs are the denominator of the FFER ratio.: $67.14
Quantile: INCY is priced correctly given its fundamentals.
Prices as of EOD 2021-06-16
Price & Estimates
Sales & Earnings history (TTM)
  • Incyte Corporation's earnings increased from -$376.05M to $478.48M in the last year.
  • Incyte Corporation's operating income increased from -$316.38M to $353.72M in the last year.
Earnings / MarketCap
Incyte Corporation
"Biotechnology" industry
Sales / MarketCap
Incyte Corporation
"Biotechnology" industry
Book / MarketCap
Incyte Corporation
"Biotechnology" industry
Equity / Assets
Incyte Corporation
"Biotechnology" industry